StockWatch
·
CHOLAMANDALAM INVESTMENT & FINANCE · Q2 FY-2027 · PREVIEW

Chola FY27: Growth Momentum Under Valuation Pressure

Street expects 24%+ revenue growth and solid PAT delivery, but stock trades near consensus targets—equity diversification and credit cost control the make-or-break reads.

Q2 FY27 resultsCHOLAFINCholamandalam Investment and Finance Company Ltd22 Oct 2026 · 3 min read

Cholamandalam enters Q2 FY27 with a clear growth narrative: core vehicle finance remains the engine, but mortgage, consumer loans, MSME, and gold finance are scaling fast. The Street expects ~24–25% YoY revenue growth and 15–20% PAT growth for the full year—rates that signal both top-line momentum and controlled credit costs. The company has raised ₹55,000 crore in NCDs and converted ₹20,000+ crore of CCDs into fresh equity, building the capital base to fund this expansion. The test: can profitability growth keep pace with the lending mix shift, or will lower-yielding mortgages and gold loans compress margins?

What to Expect

Q2 FY27 Revenue

~₹8,900–9,100 Cr

On-plan 24%+ YoY growth; Q1 FY27 was ₹8,957 Cr. Seasonal and mix-related variance normal.

Q2 FY27 EPS

~₹18.85

Analyst consensus (3 forecasters). FY27 full-year EPS guided at ₹81.1, implying steady Q-on-Q pace.

Net Interest Margin

Watch for stability

Key risk if mortgage mix accelerates faster than vehicle finance. Equity diversification critical to offset NIM pressure.

Asset Quality

NPA trends

Street assumes benign credit cost. Any NPA spike or credit cost guidance cut would weigh on PAT growth outlook.

A strong print would show revenue and PAT growth in the 24%+ and 15%+ range respectively, stable or improving NIMs despite loan-mix shifts, and management reaffirming full-year guidance without credit-cost surprises. A weak print would signal NIM compression beyond Street expectations, rising NPA, or slowing progress in non-vehicle segments despite the capital raise.

On Track?

Q1 FY27 (announced Jul 28) set the baseline: ₹8,957 Cr revenue and ₹1,656 Cr profit. Q2 needs to sustain that run-rate or show modest improvement to hit the Street's 24% YoY expectation. Analysts project FY27 revenue at ₹21,048 crore (+22.7% YoY) and full-year EPS of ₹81.1—a quarterly cadence averaging ~₹20.3 per share. Q2 at ₹18.85 is slightly below the quarterly average, which is typical mid-year (H1 often lighter than H2 in NBFC cycles). The capital raise and diversification into mortgages and gold loans are on plan; the earnings delivery hinges on credit cost stability.

What the Street Says

Since Last Quarter

Material Filings & Corporate Actions
  • 1 · Capital Raise Completed

    Board approved ₹55,000 Cr NCD programme (Jul 28). First tranche allotted: ₹2,000 Cr unsecured perpetual NCDs (Sep 1), ₹350 Cr secured NCDs (Aug 26). Programme provides dry powder for growth, but equity dilution from CCD conversions (43,000 CCDs → 30.55L shares, Sep 30) is ongoing. No dividend surprise flagged.

  • 2 · Promoter Reclassification

    Aug 26: Algavista Greentech (promoter entity) received NOC for reclassification. Promoter holding stable at ~49.2% (Q1 FY27). FII share inched down 42 bps QoQ to 24.45%; DII +71 bps to 20.62%. Routine corporate governance move.

  • 3 · Trading Window & Result Intimation

    Oct 1–30: Trading window closed for designated persons in connection with Q2 results. Board meeting set Oct 28 to approve audited standalone/consolidated P&L. Disclosure expected immediately after approval—watch for any delay or surprise statement.

  • 4 · No Negative Surprises or Insider Activity

    No pledges filed, no insider selling, no regulatory action. Sep 13: company clarified that elevated trading volume had no undisclosed information—consistent with market's seasonal churn.

The Setup

Cholamandalam enters Q2 results day as a growth story with a full quiver: vehicle finance scale, mortgage expansion, capital cushion, and Street conviction (32 analysts, 72% Buy). But the stock has given back summer gains—now 21% below ATH and trading near consensus price targets with limited near-term upside surprise built in. Results will be read against two yardsticks: (1) Did revenue and PAT growth hold the 24% and 15%+ pace? and (2) Are margins and credit costs stable enough to justify the dividend and guidance reaffirm? On the filing front, capital raise is done and dilution is visible; promoter commitment remains steady; no governance red flags. The valuation case rests on mortgage originations maturing and credit cycles staying benign.

Three Things to Watch on Oct 28

1. Margin Trajectory: Have Q2 NIMs held or compressed vs. Q1? Mortgage ramp-up is unavoidable, but if it erodes NIMs below 3.3%–3.4%, that signals pricing pressure and could spook the Street. Watch the yield on advances and cost of funds separately. 2. Credit Cost & NPA Ratio: Street assumes benign credit (1.0%–1.2% cost of credit as % of advances). Any spike, or NPA ratio creeping above 1.5%, would challenge the 15%+ PAT growth guidance. Vehicle portfolio typically clean; gold and MSME are the watch zones. 3. Diversification & Mortgage Mix: How much of Q2 originations came from non-vehicle segments? If mortgage + consumer + gold reached 30%+ of new originations, that validates the diversification thesis and supports the Street's optimism. If vehicle still >70%, growth will eventually stall.

Cholamandalam's Q2 is a straightforward test of execution under a growth thesis the Street already prices in. The company has the capital, the market tailwinds, and the management track record. The risk is not a miss—it's that the bar is high, and valuation leaves no room for a moderation. Results on Oct 28 will either reaffirm the diversification playbook or force a pullback if margins compress or credit costs spike. Coverage is deep and bullish, but the stock's sharp October decline suggests conviction is waning; a beat might reignite, a miss could accelerate the selloff.

Informational and educational content only. Not investment advice.